- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
What Risk Does the Coronavirus Pose for Cannabis Companies?
Eight Capital analyst Graeme Kreindler has shared points of concern for the Canadian cannabis industry amid the increased COVID-19 tension.
In a note issued earlier this week, a cannabis analyst offered a look at issues investors should be aware of when it comes to the spread of the novel coronavirus in Canada.
Graeme Kreindler, equity research analyst with boutique financial institution Eight Capital, indicated that the highest areas of concern across the supply chain in cannabis are lighting in the cultivation sector and vape hardware as part of manufacturing.
As safety measures are put in place for the prevention of COVID-19, the disease caused by this coronavirus, the analyst also highlighted machinery and environmental control segments attached to cannabis operations as areas to monitor.
He said that concerns over lighting equipment and vape hardware are due to connections with manufacturing in Asia, primarily China.
“This comes at a time where vape sales are expected to ramp up given their recent launch in the Canadian adult-use market and a rebound in sales in the US, after concerns late last year on vape-related illness,” Kreindler said in his note, according to a report from BNN Bloomberg.
Vape sales have become increasingly significant for companies given the recent second stage of legalization in Canada.
“Virtually all vape hardware manufactured in China per our discussions with operators. Build-up of inventory post-vape crisis could mitigate some risk. Tight capital conditions not conductive to every operator being able to build up and sustain large inventory positions,” the analyst wrote.
Kreindler covers an array of Canadian cannabis names like Tilray (NASDAQ:TLRY), Aurora Cannabis (NYSE:ACB,TSX:ACB) and Canopy Growth (NYSE:CGC,TSX:WEED), alongside US firms such as Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) and Harvest Health and Recreation (CSE:HARV,OTCQX:HRVSF).
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.